Literature DB >> 447025

Structure of bile acids associated with secretion in the rat cecum.

S J Gordon, M D Kinsey, J S Magen, R E Joseph, O D Kowlessar.   

Abstract

An isolated in vivo rat cecal loop technique was utilized to determine what structure of bile acids is required to stimulate net colonic secretion of water and sodium. A dose response curve for water and sodium movement was determined for deoxycholic acid (1-6 mM) and chenodeoxycholic acid (3-6 mM). Both of these bile acids were associated with significant secretion of water and sodium at 4 mM concentration. Therefore, this concentration was used for all test bile acids studied. Test solutions included the tri- and di-substituted bile acids: cholic acid, hyocholic acid, 3 alpha, 7 beta, 12 alpha-trihydroxycholanic acid, 3 alpha, 12 alpha-dihydroxy-7-ketocholanic acid, ursodeoxycholic acid, 3 alpha-hydroxy-7-ketocholanic acid, 7 alpha, 12 alpha-dihydroxycholanic acid, and hyodeoxycholic acid. Only three bile acids, deoxycholic acid, chenodeoxycholic acid, and 7 alpha, 12 alpha-dihydroxycholanic acid were associated with net secretion of water and sodium. Cecal histology after incubation with bile acids revealed mucosal alterations in those sacs in which secretion occurred, but not where absorption was noted. These data indicate that bile acid-associated water and sodium secretion in the rat cecum requires a specific bile acid structure with a definite spatial relationship of the hydroxyl groups. Secretion occurred only with two alpha-hydroxyl groups in either the 3, 7, or 12 positions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447025

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.

Authors:  Cédric Peleman; Michael Camilleri; Irene Busciglio; Duane Burton; Leslie Donato; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-14       Impact factor: 11.382

Review 2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

3.  Pharmacological inhibition of chenodeoxycholate-induced fluid and mucus secretion and mucosal injury in the rabbit colon.

Authors:  M Camilleri; R Murphy; V S Chadwick
Journal:  Dig Dis Sci       Date:  1982-10       Impact factor: 3.199

4.  [Pathogenic significance of bile acids (author's transl)].

Authors:  W Gerok; S Matern
Journal:  Klin Wochenschr       Date:  1981-06-15

5.  The role of bile acids in colonic carcinogenesis.

Authors:  N Breuer; H Goebell
Journal:  Klin Wochenschr       Date:  1985-02-04

6.  Independence of the activation of mucus and potassium secretion on the inhibition of sodium and water absorption by deoxycholate in rat colon.

Authors:  U M Farack; G Nell; O Lueg; W Rummel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

7.  Dose-related effects of chenodeoxycholic acid in the rabbit colon.

Authors:  M Camilleri; R Murphy; V S Chadwick
Journal:  Dig Dis Sci       Date:  1980-06       Impact factor: 3.199

8.  Differentiation of secretagogue drugs by chlorpromazine in rat intestine in vivo.

Authors:  U M Farack; G Nell; W Rummel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

9.  Mast cells and histamine contribute to bile acid-stimulated secretion in the mouse colon.

Authors:  C M Gelbmann; C D Schteingart; S M Thompson; A F Hofmann; K E Barrett
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Ursodeoxycholic acid attenuates colonic epithelial secretory function.

Authors:  Orlaith B Kelly; Magdalena S Mroz; Joseph B J Ward; Carolina Colliva; Michael Scharl; Roberto Pellicciari; John F Gilmer; Padraic G Fallon; Alan F Hofmann; Aldo Roda; Frank E Murray; Stephen J Keely
Journal:  J Physiol       Date:  2013-03-18       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.